Ovarian Cancer

• CLINICAL_TRIALS research · 2025-07-22
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery [Phase 2]

  A Phase 2 clinical trial update for SHR-2004 Injection aimed at preventing postoperative venous thromboembolism in patients undergoing ovari…

• CLINICAL_TRIALS research · 2025-07-22
  Clinical Trial Update: Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) [NA]

  A UCSF-sponsored clinical trial called 'Tools To Be Fit' aims to improve nutrition and physical activity among cancer survivors and is curre…

• CLINICAL_TRIALS research · 2025-07-22
  Clinical Trial Update: Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology [NA]

  This update concerns a clinical trial examining whether a clinician nudge to refer patients with adnexal masses to gynecologic oncology impr…

• CLINICAL_TRIALS research · 2025-07-20
  Clinical Trial Update: Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study [Phase 4]

  A prospective multicenter Phase 4 trial is assessing the safety and efficacy of combining RIF with Anlotinib in patients with advanced recur…

• CLINICAL_TRIALS research · 2025-07-20
  Clinical Trial Update: UNTOLD Ovarian Cancer Unmet Needs Survey

  A clinical trial update for UNTOLD, a survey study by the Masonic Cancer Center at the University of Minnesota to assess unmet needs in ovar…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-07-20
  Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]

  Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovar…

• CLINICAL_TRIALS research · 2025-07-20
  Clinical Trial Update: Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]

  Phase 1 clinical trial update for SYN818 in advanced or metastatic solid tumors; currently recruiting.

• CLINICAL_TRIALS research · 2025-07-20
  Clinical Trial Update: Centralization and Oncologic Outcomes in Ovarian Cancer

  Clinical trial update on centralization and oncologic outcomes in ovarian cancer; the trial is currently active but not recruiting.

• CLINICAL_TRIALS research · 2025-07-17
  Clinical Trial Update: Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

  Clinical trial update on rapid pancreatic and ovarian cancer screening MRI using motion-corrected T1, T2, and advanced diffusion-weighted im…

• CLINICAL_TRIALS research · 2025-07-17
  Clinical Trial Update: Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer

  This clinical trial investigates how metabolic biomarkers change over time in ovarian cancer and whether these changes have prognostic signi…

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer [Phase 1]

  Phase 1 bioequivalence study evaluating pharmacokinetics and safety of BR2022 and BR2022-1 in patients with deleterious BRCA-mutated advance…

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study [Phase 2]

  Phase 2 single-arm trial evaluating whether hyperthermic intraperitoneal chemotherapy (HIPEC) can enhance the efficacy of immune checkpoint …

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: ICRA Randomised Controlled Trial [Phase 3]

  A Phase 3 randomized controlled trial (ICRA) investigating treatment for ovarian cancer is listed (NCT07068464), sponsored by NHS Grampian, …

• CLINICAL_TRIALS research · 2025-07-16
  Clinical Trial Update: Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating sequential CD146 and GPC3 CAR-T cell therapy for advanced ovarian cancer and is currently recruitin…

• CLINICAL_TRIALS research · 2025-07-15
  Clinical Trial Update: A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

  This clinical trial update reports long-term follow-up of participants treated with A2 Biotherapeutics' gene therapy products in solid tumor…

• CLINICAL_TRIALS research · 2025-07-14
  Clinical Trial Update: Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies [Phase 1, Phase 2]

  SPEDOX-6, a single protein encapsulated doxorubicin, is being studied in Phase 1/2 trials for several advanced cancers and is currently recr…

• CLINICAL_TRIALS research · 2025-07-11
  Clinical Trial Update: Design and Validation of Plasma Proteins and Cytokine Panels to Identify Markers Associated With Response to Niraparib as Maintenance Treatment After First-line Platinum-based Regimen in Patients With Advanced Ovarian Cancer

  A protocol-level study to design and validate plasma protein and cytokine panels to identify biomarkers associated with response to Nirapari…

• CLINICAL_TRIALS research · 2025-07-11
  Clinical Trial Update: Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression [Phase 2]

  Phase 2 clinical trial investigating perioperative inhibition of beta-adrenergic and COX-2 signaling to reduce progression of ovarian cancer…

• CLINICAL_TRIALS research · 2025-07-10
  Clinical Trial Update: Prehabilitation in Ovarian Cancer Patients During Chemiotherapy Before Cytoreductive Surgery. [NA]

  Ongoing clinical trial update shows enrollment is open for a prehabilitation program in ovarian cancer patients undergoing chemotherapy befo…

• CLINICAL_TRIALS research · 2025-07-08
  Clinical Trial Update: RC48 in Combination With AK104 and Bevacizumab in OCCC [Phase 2]

  Phase 2 clinical trial evaluating RC48 in combination with AK104 and bevacizumab for ovarian cancer, including ovarian clear cell carcinoma,…

• CLINICAL_TRIALS research · 2025-07-03
  Clinical Trial Update: A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation

  A non-interventional prospective study evaluating first-line treatment approaches for HRD-positive ovarian cancer patients in the Russian Fe…

• CLINICAL_TRIALS research · 2025-07-02
  Clinical Trial Update: Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]

  Phase 2 study evaluating personalized timing of interval debulking surgery for advanced ovarian cancer. The trial is currently recruiting.

• CLINICAL_TRIALS research · 2025-07-01
  Clinical Trial Update: Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]

  Phase 1 trial update on TAG72-CAR T cells for platinum-resistant epithelial ovarian cancer, with the study currently recruiting.

• CLINICAL_TRIALS research · 2025-07-01
  Clinical Trial Update: Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients [NA]

  A clinical trial update indicates a study is currently recruiting to compare short-term fasting with a free diet in patients with ovarian ca…

• CLINICAL_TRIALS research · 2025-06-30
  Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

  Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; th…